Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 NEXT DPI versus pMDI lung bioavailability study in adults with asthma
2010-024384-40Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of beclometasone dipropionate + formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Plasma B17MP AUC0-t, Plasma formoterol AUC0-t and 1 more. Started Apr 2011; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-024384-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024384-40.